Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes
Clinical trial NCT02637973 · COMPLETED
Trial details
- NCT number
- NCT02637973
- Sponsor
- The Deutsche Diabetes Forschungsgesellschaft e.V.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-08-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.